Pfizer Inc (MIL:1PFE)
€ 24.625 -0.16 (-0.65%) Market Cap: 138.78 Bil Enterprise Value: 192.52 Bil PE Ratio: 34.89 PB Ratio: 1.59 GF Score: 64/100

Pfizer Inc at Sanford C Bernstein Strategic Decisions Conference Transcript

Jun 01, 2022 / 01:00PM GMT
Aaron Gal
Sanford C. Bernstein & Co., LLC., Research Division - Senior Research Analyst

Okay, guys. Let us go ahead and start. Thank you for being here today. And obviously, it's one of the -- we rarely ever have a celebrity here, and Albert has now gotten to a point where he's a bit of the ambassador for the drug industry and what it can do to help the human race. So Albert, thank you and through you all the Pfizer folks who work so hard on helping us being able to hold this event in-person and helping us move to the post-COVID period.

Albert Bourla
Pfizer Inc. - Chairman of the Board & CEO

No, thank you. And on behalf of all Pfizer colleagues, and I hope you will do the same in Novartis now that you're going.

Aaron Gal
Sanford C. Bernstein & Co., LLC., Research Division - Senior Research Analyst

Thank you. Well, we'll try to match you guys at some point with equivalently valuable innovation.

Albert Bourla
Pfizer Inc. - Chairman of the Board & CEO

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot